Literature DB >> 10854209

Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction.

U Lehmann1, S Glöckner, W Kleeberger, H F von Wasielewski, H Kreipe.   

Abstract

Gene amplification is one of the most important mechanisms leading to deregulated gene expression in cancer. The exact quantitative detection of this frequent genomic alteration in solid tumors is often hampered by an admixture of nonneoplastic bystander and stroma cells. To overcome this obstacle and to develop an objective quantitative method we have combined laser-assisted microdissection of tumor cells with the novel 5'-exonuclease-based real-time polymerase chain reaction (PCR) assay. The latter method enables the highly reproducible exact quantification of minute amounts of nucleic acids. As a model system amplification of c-erbB2/Her-2/neu gene and the adjacent topoisomerase IIalpha gene was determined in paraffin-embedded breast cancer specimens (n = 23) after immunohistochemical labeling and laser-based microdissection of tumor cells. The high sensitivity of real-time PCR enabled the reliable and objective detection of low-level amplifications in as few as 50 cells from archival tissue sections. Low-level amplifications were shown to escape from detection unless tumor cells were isolated by microdissection. In selected cases intratumor heterogeneity was demonstrated using areas of approximately 50 to 100 cells. This novel approach combining immunohistochemistry, laser microdissection, and quantitative kinetic PCR allows morphology-guided studies in archival tissue specimens and will enable the exact quantification of gene copy numbers in even small and precancerous lesions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854209      PMCID: PMC1850085          DOI: 10.1016/S0002-9440(10)65059-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis.

Authors:  A Abou-Elella; T Gramlich; C Fritsch; T Gansler
Journal:  Mod Pathol       Date:  1996-02       Impact factor: 7.842

2.  Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase II alpha. Delineation of a carboxy-terminal epitope with peptide antibodies.

Authors:  F Boege; A Andersen; S Jensen; R Zeidler; H Kreipe
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

Review 3.  Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors.

Authors:  L N Klapper; M H Kirschbaum; M Sela; Y Yarden
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

4.  A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1.

Authors:  H Kreipe; H J Heidebrecht; S Hansen; W Röhlk; M Kubbies; H H Wacker; M Tiemann; H J Radzun; R Parwaresch
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

5.  Topoisomerase II alpha co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity.

Authors:  K Smith; S Houlbrook; M Greenall; J Carmichael; A L Harris
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

6.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase.

Authors:  P M Holland; R D Abramson; R Watson; D H Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

7.  Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization.

Authors:  K J Livak; S J Flood; J Marmaro; W Giusti; K Deetz
Journal:  PCR Methods Appl       Date:  1995-06

8.  ERBB-2 (HER2/neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer.

Authors:  J Szöllösi; M Balázs; B G Feuerstein; C C Benz; F M Waldman
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

Review 9.  Amplification of N-myc as a prognostic marker for patients with neuroblastoma.

Authors:  M Schwab
Journal:  Semin Cancer Biol       Date:  1993-02       Impact factor: 15.707

10.  Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization.

Authors:  D Pinkel; T Straume; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more
  30 in total

1.  Persistent p53 mutations in single cells from normal human skin.

Authors:  G Ling; A Persson; B Berne; M Uhlén; J Lundeberg; F Ponten
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

2.  Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction: a methodological study on lymph nodes from melanoma patients.

Authors:  Helene Nortvig Abrahamsen; Torben Steiniche; Ebba Nexo; Stephen J Hamilton-Dutoit; Boe Sandahl Sorensen
Journal:  J Mol Diagn       Date:  2003-02       Impact factor: 5.568

3.  Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays.

Authors:  Marina Bibikova; Dimitri Talantov; Eugene Chudin; Joanne M Yeakley; Jing Chen; Dennis Doucet; Eliza Wickham; David Atkins; David Barker; Mark Chee; Yixin Wang; Jian-Bing Fan
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

4.  Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer.

Authors:  Anna Zaczek; Aleksandra Markiewicz; Anna Supernat; Natalia Bednarz-Knoll; Burkhardt Brandt; Barbara Seroczyńska; Jarosław Skokowski; Jolanta Szade; Piotr Czapiewski; Wojciech Biernat; Marzena Wełnicka-Jaśkiewicz; Jacek Jassem
Journal:  Pathol Oncol Res       Date:  2012-03-18       Impact factor: 3.201

5.  Chimerism of metanephric adenoma but not of carcinoma in kidney transplants.

Authors:  Michael Mengel; Danny Jonigk; Ludwig Wilkens; Jörg Radermacher; Reinhard von Wasielewski; Ulrich Lehmann; Hermann Haller; Michael Mihatsch; Hans Kreipe
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

6.  Accurate breast cancer diagnosis through real-time PCR her-2 gene quantification using immunohistochemically-identified biopsies.

Authors:  Gretel Mendoza; Amelia Portillo; Jorge Olmos-Soto
Journal:  Oncol Lett       Date:  2012-10-22       Impact factor: 2.967

Review 7.  [Translational research and diagnostics for breast cancer].

Authors:  H H Kreipe
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 8.  Laser capture microdissection and advanced molecular analysis of human breast cancer.

Authors:  Andrew P Fuller; Darryl Palmer-Toy; Mark G Erlander; Dennis C Sgroi
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

9.  Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma.

Authors:  Fabíola E Rosa; Sara M Silveira; Cássia G T Silveira; Nádia A Bérgamo; Francisco A Moraes Neto; Maria A C Domingues; Fernando A Soares; José R F Caldeira; Silvia R Rogatto
Journal:  BMC Cancer       Date:  2009-03-23       Impact factor: 4.430

10.  Identification of novel reference genes using multiplatform expression data and their validation for quantitative gene expression analysis.

Authors:  Mi Jeong Kwon; Ensel Oh; Seungmook Lee; Mi Ra Roh; Si Eun Kim; Yangsoon Lee; Yoon-La Choi; Yong-Ho In; Taesung Park; Sang Seok Koh; Young Kee Shin
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.